Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 2/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7037368 | 0.81 | MTNR1A (0.47) | MTNR1AMTNR1BLMNAMAOAPTGS1 | |
| SCHEMBL13941995 | 0.80 | MTNR1A (0.49) | MTNR1AMTNR1BLMNAMAOAPTGS1 | |
| SCHEMBL14018476 | 0.78 | THRB (0.43) | LMNAMAOAPTGS1LTA4HKDM4E | |
| SCHEMBL4633428 | 0.77 | MTNR1A (0.46) | MTNR1AMTNR1BLMNAMAOAPTGS1 | |
| SCHEMBL2505117 | 0.76 | LMNA (0.61) | MTNR1AMTNR1BLMNAMAOAPTGS1 | |
| SCHEMBL1684306 | 0.75 | CYP2C19 (0.35) | LMNACA4POLB | |
| SCHEMBL181493 | 0.75 | TSHR (0.56) | MTNR1AMTNR1BLMNA | |
| SCHEMBL5799634 | 0.75 | MTNR1A (0.47) | MTNR1AMTNR1BLMNAMAOAPTGS1 | |
| SCHEMBL31387057 | 0.74 | MTNR1A (0.44) | MTNR1AMTNR1BLMNAMAOAPTGS1 | |
| SCHEMBL31387112 | 0.74 | MTNR1A (0.44) | MTNR1AMTNR1BLMNAMAOAPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0540730-B1 | SOLUBLE PERFLUOROELASTOMERS AND USE IN PELLICLES | DU PONT (US) | 1997-12-29 | — | — | EP | claimed |
| US-5168001-A | Perfluoropolymer coated pellicle | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-12-01 | — | — | US | claimed |
| US-4320216-A | Fluoroelastomer gelling agents and products made therefrom | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-03-16 | — | — | US | claimed |
| CN-116234794-B | Low reactivity hydrocarbon dispersants in aqueous polymerization of fluoropolymers | THE CHEMOURS COMPANY FC, LLC (US) | 2026-05-26 | — | — | CN | disclosed |
| EP-4222141-B1 | LOW REACTIVITY HYDROCARBON DISPERSING AGENTS IN THE AQUEOUS POLYMERIZATION OF FLUOROPOLYMERS | CHEMOURS CO FC LLC (US) | 2025-08-06 | — | — | EP | disclosed |
| US-20240002553-A1 | EMPLOYING LOW REACTIVITY HYDROCARBON DISPERSING AGENT IN AQUEOUS POLYMERIZATION OF FLUOROPOLYMERS | THE CHEMOURS COMPANY FC, LLC (US) | 2024-01-04 | — | — | US | disclosed |
| EP-4222141-A1 | LOW REACTIVITY HYDROCARBON DISPERSING AGENTS IN THE AQUEOUS POLYMERIZATION OF FLUOROPOLYMERS | The Chemours Company FC, LLC (US) | 2023-08-09 | — | — | EP | disclosed |
| CN-116234794-A | Low reactivity hydrocarbon dispersants in aqueous polymerization of fluoropolymers | 科慕埃弗西有限公司 | 2023-06-06 | — | — | CN | disclosed |
| EP-3091039-B1 | FLUOROPOLYMER PRODUCED BY AQUEOUS POLYMERIZATION USING DISPERSED PARTICULATE OF FLUORINATED IONOMER | CHEMOURS CO FC LLC (US) | 2023-03-01 | — | — | EP | disclosed |
| US-20220389128-A1 | AQUEOUS POLYMERIZATION OF FLUORINATED MONOMER USING POLYMERIZATION AGENT COMPRISING FLUOROPOLYETHER ACID OR SALT AND SHORT CHAIN FLUOROSURFACTANT | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2022-12-08 | — | — | US | disclosed |
| US-11440981-B2 | Aqueous polymerization of fluorinated monomer using polymerization agent comprising fluoropolyether acid or salt and short chain fluorosurfactant | THE CHEMOURS COMPANY FC, LLC (US) | 2022-09-13 | — | — | US | disclosed |
| CN-101006133-A | Blends of perfluoroelastomers and fluoroplastics | DUPONT PERFORMANCE ELASTOMERS (US) | 2007-07-25 | — | — | CN | disclosed |
| EP-0540730-B1 | SOLUBLE PERFLUOROELASTOMERS AND USE IN PELLICLES | DU PONT (US) | 1997-12-29 | — | — | EP | disclosed |
| EP-0540730-A1 | SOLUBLE PERFLUOROELASTOMERS AND USE IN PELLICLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-05-12 | — | — | EP | disclosed |
| US-5168001-A | Perfluoropolymer coated pellicle | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-12-01 | — | — | US | disclosed |
| US-5168001-A | Perfluoropolymer coated pellicle | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-12-01 | — | — | US | disclosed |
| WO-1992020720-A1 | SOLUBLE PERFLUOROELASTOMERS AND USE IN PELLICLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-11-26 | — | — | WO | disclosed |
| EP-0105445-A1 | Perfluoroelastomer blends | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-04-18 | — | — | EP | disclosed |
| US-4413094-A | TETRAFLUOROETHYLENE-PERFLUOROMETHYL PERFLUOROVINYL ETHER TERPOLYMER AND HEXAFLUOROPROPYLENE OXIDE COPOLYMER | E. I. DU PONT DE NEMOURS & CO. (US) | 1983-11-01 | — | — | US | disclosed |
| US-4320216-A | Fluoroelastomer gelling agents and products made therefrom | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002553-A1 | EMPLOYING LOW REACTIVITY HYDROCARBON DISPERSING AGENT IN AQUEOUS POLYMERIZATION OF FLUOROPOLYMERS | FPR1, NAF1, SIGMAR1 | MTNR1A 822/4885MTNR1B 1021/4885LMNA 497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.